Capital International Investors Ab Cellera Biologics Inc. Transaction History

Capital International Investors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.72 - $10.65 $15 Million - $28 Million	-2,626,644 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.46 - $14.14 $41.1 Million - $77.8 Million	-5,505,307 Reduced 67.7%	2,626,644 $25.6 Million
Q4 2021 Feb 14, 2022	BUY	$12.99 - $17.73 $13.3 Million - $18.1 Million	1,022,062 Added 14.38%	8,131,951 $116 Million
Q3 2021 Nov 15, 2021	BUY	$14.85 - $21.34 $3.2 Million - $4.61 Million	215,800 Added 3.13%	7,109,889 $142 Million
Q2 2021 Aug 16, 2021	BUY	$20.19 - $34.17 $103 Million - $174 Million	5,097,178 Added 283.66%	6,894,089 $152 Million
Q1 2021 May 14, 2021	BUY	$23.29 - $53.2 $24.4 Million - $55.7 Million	1,046,911 Added 139.59%	1,796,911 $61 Million
Q4 2020 Feb 12, 2021	BUY	$39.0 - $58.9 $29.3 Million - $44.2 Million	750,000 New	750,000 $30.2 Million

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $813M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

Stay updated on Capital International Investors with notifications on news.